Senescence and Cell Death Pathways and Their Role in Cancer Therapeutic Outcome

被引:33
|
作者
Chiantore, M. V.
Vannucchi, S.
Mangino, G. [2 ]
Percario, Z. A. [2 ]
Affabris, E. [2 ]
Fiorucci, G. [3 ]
Romeo, G. [1 ,3 ]
机构
[1] Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy
[2] Univ Roma Tre, Dept Biol, Rome, Italy
[3] CNR, Inst Mol Biol & Pathol, I-00185 Rome, Italy
关键词
Senescence; apoptosis; autophagy; cancer therapy; ONCOGENE-INDUCED SENESCENCE; MALIGNANT GLIOMA-CELLS; HUMAN-DIPLOID FIBROBLASTS; DRUG-INDUCED APOPTOSIS; RAS-INDUCED SENESCENCE; DNA-DAMAGE RESPONSE; NF-KAPPA-B; REPLICATIVE SENESCENCE; PREMATURE SENESCENCE; TUMOR SUPPRESSION;
D O I
10.2174/092986709787002691
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Anticancer drug-induced tumor suppression may involve mechanisms of protection against neoplastic transformation that are normally latent in mammalian cells and consist in a genetic program implemented during anti-tumoral defense. This defense program results in the self elimination of cells harboring potentially dangerous mutations by triggering cell death through apoptosis and/or autophagy or in the execution of a program that leads to a permanent growth arrest known as senescence. These responses are considered crucial tumor suppressive mechanisms and their study appears to be essential to develop therapeutical procedures based on the enhancement of the different responses. This review summarizes fundamental knowledge on the underlying mechanisms able to limit excessive or aberrant cellular proliferation and on the prognostic value of both apoptosis and senescence detection. In addition, interesting evidence showing that different drugs induce senescence or cell death depending on the genetic features of the tumor cells as well as on the integrity of the relative pathways is reported.
引用
收藏
页码:287 / 300
页数:14
相关论文
共 50 条
  • [1] Cell death pathways as therapeutic targets for cancer
    Karantza-Wadsworth, V.
    Patel, S.
    Jin, S.
    Rubin, E.
    White, E.
    EJC SUPPLEMENTS, 2006, 4 (12): : 124 - 124
  • [2] Therapeutic targeting of death pathways in cancer - Mechanisms for activating cell death in cancer cells
    Tan, Ting-Ting
    White, Eileen
    PROGRAMMED CELL DEATH IN CANCER PROGRESSION AND THERAPY, 2008, 615 : 81 - 104
  • [3] Cell death pathways: molecular mechanisms and therapeutic targets for cancer
    Wang, Shaohui
    Guo, Sa
    Guo, Jing
    Du, Qinyun
    Wu, Cen
    Wu, Yeke
    Zhang, Yi
    MEDCOMM, 2024, 5 (09):
  • [4] Senescence and cancer — role and therapeutic opportunities
    Clemens A. Schmitt
    Boshi Wang
    Marco Demaria
    Nature Reviews Clinical Oncology, 2022, 19 : 619 - 636
  • [5] Senescence and cancer - role and therapeutic opportunities
    Schmitt, Clemens A.
    Wang, Boshi
    Demaria, Marco
    NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (10) : 619 - 636
  • [6] The role of apoptosis in cancer cell survival and therapeutic outcome
    Kim, Ryungsa
    Emi, Manabu
    Tanabe, Kazuaki
    CANCER BIOLOGY & THERAPY, 2006, 5 (11) : 1429 - 1442
  • [7] Activation of Pyroptotic Cell Death Pathways in Cancer: Alternative Therapeutic approach
    Nagarajan, Kanipandian
    Soundarapandian, Kannan
    Thorne, Rick F.
    Li, Dongxiao
    Li, Deyu
    TRANSLATIONAL ONCOLOGY, 2019, 12 (07): : 925 - 931
  • [8] Apoptosis as a therapeutic strategy for breast cancer: the role of Thymax, a gross thymic extract, in modulating cell death pathways
    Elwakkad, Amany
    El Din, Amina A. Gamal
    Hebishy, Mohamed A.
    Abou-Seif, Howida S.
    EGYPTIAN PHARMACEUTICAL JOURNAL, 2024, 23 (02) : 184 - 198
  • [9] Cell death pathways - potential therapeutic targets
    MacFarlane, M.
    XENOBIOTICA, 2009, 39 (08) : 616 - 624
  • [10] Lysosomal pathways to cell death and their therapeutic applications
    Cesen, Marusa Hafner
    Pegan, Katarina
    Spes, Ales
    Turk, Boris
    EXPERIMENTAL CELL RESEARCH, 2012, 318 (11) : 1245 - 1251